药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Halothane
Methylenedioxyethamphetamine
Methylenedioxyethamphetamine may decrease the sedative and stimulatory activities of Levocetirizine.
Halothane
Chlorphentermine
Chlorphentermine may decrease the sedative and stimulatory activities of Levocetirizine.
Halothane
Tenamfetamine
Tenamfetamine may decrease the sedative and stimulatory activities of Levocetirizine.
Halothane
4-Bromo-2,5-dimethoxyamphetamine
4-Bromo-2,5-dimethoxyamphetamine may decrease the sedative and stimulatory activities of Levocetirizine.
Halothane
2,5-Dimethoxy-4-ethylamphetamine
2,5-Dimethoxy-4-ethylamphetamine may decrease the sedative and stimulatory activities of Levocetirizine.
Halothane
MMDA
MMDA may decrease the sedative and stimulatory activities of Levocetirizine.
Halothane
Mephentermine
Mephentermine may decrease the sedative and stimulatory activities of Levocetirizine.
Halothane
Alaproclate
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Alaproclate.
Halothane
Ritanserin
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Ritanserin.
Halothane
Indalpine
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Indalpine.
Halothane
Levomilnacipran
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Levomilnacipran.
Halothane
Seproxetine
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Seproxetine.
Halothane
Desvenlafaxine
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Desvenlafaxine.
Halothane
Milnacipran
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Milnacipran.
Halothane
Dapoxetine
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Dapoxetine.
Halothane
Betahistine
The therapeutic efficacy of Betahistine can be decreased when used in combination with Levocetirizine.
Halothane
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Levocetirizine.
Halothane
Suvorexant
Levocetirizine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Halothane
Sodium oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Levocetirizine.
Halothane
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Levocetirizine.